A multicentric phase II-III randomized study safety of intravenous liposomal pegylated doxorubicin versus continuous infusion of doxorubicin during induction treatment of acute lymphoblastic leukemia in patients

Trial Profile

A multicentric phase II-III randomized study safety of intravenous liposomal pegylated doxorubicin versus continuous infusion of doxorubicin during induction treatment of acute lymphoblastic leukemia in patients

Completed
Phase of Trial: Phase II/III

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Mercaptopurine; Methotrexate; Tioguanine; Vincristine
  • Indications Acute lymphoblastic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top